October 21, 2014—Hospital groups are applauding federal health officials for telling drugmakers they owe rural and freestanding cancer hospitals refunds for overcharges on orphan drugs.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register.
Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)